Oxford BioMedica PLCHere is the public summary page for Oxford BioMedica PLC. Please login to see the complete information for Oxford BioMedica PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Oxford BioMedica PLC stacks up relative to its peers. |
| Darwin Score | +28 |
| Ticker | OXB |
| Latest Price | 3.83 GBX as of close on 25-Jul-2025 |
| 3 Month price range | 2.77 to 3.87 GBX |
| Market Capitalisation | 410.22Mn GBX |
| Country | UK |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. See More ... |
| Company URL | https://www.oxb.com |
| See Darwins Full Analysis for Oxford BioMedica PLC |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Oxford BioMedica PLC. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +21 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +7 |
Alerts
There are 7 live alerts for Oxford BioMedica PLC.
- Overbought - The 30 day RSI is +70.9. (Negative)
- Overbought - The 15 week RSI is +72.3. (Negative)
- Overbought - The 5 month RSI is +76.5. (Negative)
- 30d RSI Overbought. This alert has occurred 5 times over the last last year. The average forward returns are -6.8% over 5 days, -5.7% over 10 days, -5.7% over 15 days and -5.9% over 20 days. (Positive)
- 15d RSI Overbought. This alert has occurred 20 times over the last last year. The average forward returns are -1.8% over 5 days, -1.2% over 10 days, -1.6% over 15 days and -1.1% over 20 days. (Positive)
- Divergence: Px Up & 5d RSI Down last 10 days. This alert has occurred 45 times over the last last year. The average forward returns are 0.6% over 5 days, 1.6% over 10 days, 0.8% over 15 days and 1.3% over 20 days. (Negative)
- Technically Overbought - 14 day RSI above 70. This alert has occurred 25 times over the last last year. The average forward returns are -1.4% over 5 days, -0.4% over 10 days, -0.4% over 15 days and -0.1% over 20 days. (Positive)
Peer Comparison
There are 6 peers of Oxford BioMedica PLC.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Angle PLC (AGL) | Biotechnology | -22 |
| Genus PLC (GNS) | Biotechnology | +13 |
| Haleon PLC (HLN) | Biotechnology | +10 |
| Oxford Nanopore Technologies PLC (ONT) | Biotechnology | +13 |
| Physiomics PLC (PYC) | Biotechnology | -12 |
| Shield Therapeutics PLC (STX) | Biotechnology | +24 |
Share 
